Colcrys for Acute Gout Camp Lejeune NC

Colcrys has been approved by the U.S. Food and Drug Administration to treat acute gout and familial Mediterranean fever (FMF), two inflammatory disorders. The drug's active ingredient, colchicine, is derived from the dried seeds of the autumn crocus plant.

Charles Edward McCannon, MD
(301) 295-3717
Camp Lejeune, NC
Specialties
Preventive Medicine, Aerospace Medicine, General Practice
Gender
Male
Education
Medical School: Uniformed Services Univ Of The Hlth Sci, Bethesda Md 20814
Graduation Year: 1994

Data Provided by:
Philip Adam ZurOwsky
(910) 450-4840
1100 Brewster Blvd
Camp Lejeune, NC
Specialty
Internal Medicine, Emergency Medicine

Data Provided by:
Earlie T Johnson
(910) 346-1188
2580 Henderson Dr
Jacksonville, NC
Specialty
Internal Medicine

Data Provided by:
Yvette Longoria
(910) 577-2240
317 Western Blvd
Jacksonville, NC
Specialty
General Practice, Emergency Medicine

Data Provided by:
Sarah E Ahrens
(910) 577-2360
317 Western Blvd
Jacksonville, NC
Specialty
Internal Medicine

Data Provided by:
Richard O'neal Lynch
(910) 451-5243
119 C Street
Camp Lejeune, NC
Specialty
Family Practice

Data Provided by:
Michael Durant Murphy
(910) 577-2360
317 Western Blvd
Jacksonville, NC
Specialty
Internal Medicine

Data Provided by:
Marshall Brantley Frink, MD
Jacksonville, NC
Specialties
General Practice
Gender
Male
Education
Medical School: Bowman Gray Sch Of Med Of Wake Forest Univ, Winston-Salem Nc 27157
Graduation Year: 1981

Data Provided by:
Adesola Awomolo
(910) 455-5511
221 Memorial Drive
Jacksonville, NC
Specialty
Internal Medicine

Data Provided by:
Eusebio Chiong Desuyo
(910) 455-9398
3652 Henderson Dr
Jacksonville, NC
Specialty
Internal Medicine, Pulmonary Disease, Critical Care (Intensivists)

Data Provided by:
Data Provided by:

Colcrys for Acute Gout

Provided By:

Colcrys has been approved by the U.S. Food and Drug Administration to treat acute gout and familial Mediterranean fever (FMF), two inflammatory disorders. The drug's active ingredient, colchicine, is derived from the dried seeds of the autumn crocus plant.

In a news release, the agency said colchicine has been used as a remedy to treat acute gout flares "for many years," despite that it hadn't been FDA approved. The agency said it was in the midst of a program to bring other similarly unapproved products under its regulatory authority.

A dosing study required for approval led the agency to recommend a lower dosing regimen for Colcrys that had been commonly prescribed, the news release said. This was designed to prevent gastrointestinal problems.

The FDA said it was alerting healthcare professionals of the lower dosing schedule and also warning that the drug had the potential for severe interactions with other medications.

FMF, common in Mediterranean nations but less so in the United States, has symptoms including fever, arthritis, and inflammation of the lining of the lungs and abdomen. Colcrys is now the first drug that's been FDA-approved to treat FMF, the agency said.

The drug is produced by Philadelphia-based Mutual Pharmaceutical Company Inc.

More information

The FDA has more about this medication's approval.

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com